Related Experiment Video

Updated: May 30, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

MYC and Breast Cancer

Jinhua Xu1, Yinghua Chen, Olufunmilayo I Olopade

  • 1Center for Clinical Cancer Genetics, Department of Medicine, University of Chicago, Chicago, IL, USA.

Genes & Cancer
|July 23, 2011
PubMed

Insights

MYC deregulation drives breast cancer, particularly the aggressive basal-like subtype. Targeting MYC pathways offers a promising therapeutic strategy for this challenging cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYC is a crucial regulator of cell functions, and its deregulation is implicated in breast cancer development and progression.
  • Breast cancer exhibits heterogeneity, with the basal-like subtype characterized by poor prognosis and limited therapeutic options.
  • MYC overexpression is common in basal-like breast cancer, suggesting its potential as a therapeutic target.

Purpose of the Study:

  • To investigate the role of MYC deregulation in breast cancer, with a focus on the basal-like subtype.
  • To explore the relationship between MYC, BRCA1, and breast cancer development.
  • To identify potential therapeutic strategies targeting MYC in breast cancer.

Main Methods:

  • Review of existing literature on MYC's role in cell biology and breast cancer.
  • Analysis of gene expression profiles and correlations with clinical outcomes.
  • Examination of the interplay between MYC and tumor suppressors like BRCA1.

Main Results:

  • MYC deregulation, through mechanisms like gene amplification and altered regulation, contributes to breast cancer.
  • Loss of BRCA1, a MYC inhibitor, combined with MYC overexpression, promotes basal-like breast cancer.
  • MYC's involvement in key signaling pathways may confer resistance to therapies.

Conclusions:

  • MYC is a significant driver in breast cancer, especially the basal-like subtype.
  • Targeting MYC and its associated pathways, potentially in combination with other inhibitors, presents a promising therapeutic avenue.
  • Further research into MYC-targeted therapies could improve outcomes for breast cancer patients, particularly those with the basal-like subtype.
Keywords:
BRCA1MYCbasal-like subtypebreast cancer

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland06:29

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...